NIH #5P30CA016087-45
Leadership, Planning and Evaluation
Active
- Amount
- $658K
- Period
- 1996-12-01 → 2029-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
NIH #5P30CA016087-44
Cancer Center Support Grant
Active
- Amount
- $4.0M
- Period
- 1996-12-01 → 2029-02-28
- PIs
- 1
- Est. capacity / PI
- ~5 students
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
NIH #7U54CA274371-04
TBEL Admin Core
Active
- Amount
- $197K
- Period
- 2022-09-21 → 2027-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
NIH #7U01CA200468-09
Clinical Validation Center for Early Detection of Pancreatic Cancer
Active
- Amount
- $1.1M
- Period
- 2016-05-04 → 2027-08-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
NIH #7U24CA274274-04
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
Active
- Amount
- $1.0M
- Period
- 2022-09-16 → 2027-08-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE
NIH #5U54CA274371-02
TBEL Admin Core
Active
- Amount
- $487K
- Period
- 2022-09-21 → 2027-08-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U24CA274274-02
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
Active
- Amount
- $972K
- Period
- 2022-09-16 → 2027-08-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA200468-07
Clinical Validation Center for Early Detection of Pancreatic Cancer
Active
- Amount
- $996K
- Period
- 2016-05-04 → 2027-08-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #1U54CA274371-01
TBEL Admin Core
Active
- Amount
- $152K
- Period
- 2022-09-21 → 2027-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #1U24CA274274-01
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
Active
- Amount
- $972K
- Period
- 2022-09-16 → 2027-08-31
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #2U01CA200468-06
Clinical Validation Center for Early Detection of Pancreatic Cancer
Active
- Amount
- $737K
- Period
- 2016-05-04 → 2027-08-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U24CA274274-03
PASSCODE (Pancreatic Adenocarcinoma Stromal Reprograming ConSortium COordination, Data Management and Education)
- Amount
- $972K
- Period
- 2022-09-16 → 2025-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U54CA274371-03
TBEL Project 2
- Amount
- $282K
- Period
- 2022-09-21 → 2025-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01CA200468-08
Clinical Validation Center for Early Detection of Pancreatic Cancer
- Amount
- $966K
- Period
- 2016-05-04 → 2025-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U54CA274371-03S1
TBEL Admin Core
- Amount
- $200K
- Period
- 2022-09-21 → 2025-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK126365-05
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer
- Amount
- $323K
- Period
- 2020-09-05 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK108328-10
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
- Amount
- $2.2M
- Period
- 2015-09-28 → 2025-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK126365-04
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer
- Amount
- $351K
- Period
- 2020-09-05 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK108328-09
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
- Amount
- $1.8M
- Period
- 2015-09-28 → 2025-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK126365-03
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer
- Amount
- $263K
- Period
- 2020-09-05 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK108328-08
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
- Amount
- $1.8M
- Period
- 2015-09-28 → 2025-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK108328-07
Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordinating and Data Management Center (CSCPDPC-CDMC)
- Amount
- $2.3M
- Period
- 2015-09-28 → 2025-06-30
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U01DK126365-02
The Texas-Louisiana Alliance to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer
- Amount
- $453K
- Period
- 2020-09-05 → 2025-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA221707-05
Developmental Research Program
- Amount
- $146K
- Period
- 2019-08-20 → 2025-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218230-05
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
- Amount
- $651K
- Period
- 2018-07-01 → 2024-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA220236-06
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
- Amount
- $348K
- Period
- 2017-09-14 → 2024-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA221707-04
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
- Amount
- $2.2M
- Period
- 2019-08-20 → 2024-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA220236-05
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
- Amount
- $359K
- Period
- 2017-09-14 → 2024-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA221707-03
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
- Amount
- $2.0M
- Period
- 2019-08-20 → 2024-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA220236-04
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
- Amount
- $366K
- Period
- 2017-09-14 → 2024-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5P50CA221707-02
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
- Amount
- $2.3M
- Period
- 2019-08-20 → 2024-05-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218230-04
Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies
- Amount
- $664K
- Period
- 2018-07-01 → 2023-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5U24CA224020-03
Pancreatic Ductal Adenocarcinoma Translational Resource Center (PATReC)
- Amount
- $560K
- Period
- 2017-09-30 → 2022-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #3U01CA200468-05S1
A Clinical Validation Center for Early Detection of Pancreatic Cancer
- Amount
- $533K
- Period
- 2016-05-04 → 2022-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218004-04
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
- Amount
- $596K
- Period
- 2018-04-04 → 2022-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR
NIH #5R01CA218004-03
Translational Applications in an Animal Model of Pancreatic Cystic Neoplasm and Cancer
- Amount
- $598K
- Period
- 2018-04-04 → 2022-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR